Wordt geladen...
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
INTRODUCTION: Synaptic dysfunction and degeneration is one of the earliest events in Alzheimer's disease (AD) and the best correlate of cognitive decline. Thus, identification and validation of biomarkers reflecting synaptic degeneration to be used as prognostic biomarkers are greatly needed. M...
Bewaard in:
| Gepubliceerd in: | Alzheimers Dement (Amst) |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087978/ https://ncbi.nlm.nih.gov/pubmed/33969172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12179 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|